Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation
Launched by N.N. PETROV NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY · Sep 15, 2022
Trial Information
Current as of May 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether a specific way of preparing the bowel before colon cancer surgery leads to better short-term outcomes than having no preparation at all. The preparation being studied involves a combination of mechanical bowel preparation (which involves clearing out the intestines) and taking oral antibiotics. Researchers want to find out if this approach helps patients recover more effectively after their surgery.
To join the study, participants must be at least 18 years old and have a confirmed diagnosis of colon cancer that is operable. They should be in reasonably good health, meaning they can perform daily activities with little assistance. However, certain conditions may prevent someone from participating, like being pregnant, having other serious medical issues, or having had antibiotics recently. If you choose to take part, you will receive care and support throughout the trial, and the results may help improve future treatment for colon cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • histologically confirmed adenocarcinoma of the colon (caecum, ascending, transverse, descending, sigmoid)
- • clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable)
- • indications for surgical colonic resection
- • ECOG status 0-2
- • At least 18 years of age
- • Written informed consent
- Exclusion Criteria:
- • Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol
- • Pregnancy or breast feeding
- • Medical contraindications for surgical treatment
- • Any use of antibiotics 30 days prior to inclusion
- • Functioning stoma
- • Contraindications for use of MBP or OA drugs or their components
- • Indications for mandatory MBP (planned intraoperative colonoscopy etc)
- • Indications for obstructive resection
- • Acute bowel obstruction, bleeding or perforation
- • Other malignancies not in remission
About N.N. Petrov National Medical Research Center Of Oncology
The N.N. Petrov National Medical Research Center of Oncology is a leading institution in cancer research and treatment, dedicated to advancing the understanding and management of oncological diseases. Located in Russia, the center is renowned for its commitment to innovative clinical trials, cutting-edge research, and the development of new therapeutic strategies. With a multidisciplinary team of experts, the center fosters collaboration between clinicians and researchers to enhance patient care and improve outcomes in oncology. Its focus on translational medicine ensures that scientific discoveries are rapidly transformed into effective clinical applications, positioning the center at the forefront of cancer research in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Petersburg, , Russian Federation
Patients applied
Trial Officials
Aleksei Karachun
Study Chair
N.N. Petrov National Medical Research Center of Oncology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials